Search Results - "Sobel, J.D."

9: Utilization of molecular methods to evaluate vaginal microbiota in a longitudinal study of recurrent bacterial vaginosis by Hilbert, D.W, Adelson, M.E, Mordechai, E, Sobel, J.D, Gygax, S.E

Get full text

18: NDV-3A vaccine reduces the frequency of vaginitis in patients with recurrent vulvovaginal candidiasis by Nyirjesy, P, Sobel, J.D, Edwards, J.E, Schwarz, M.W, Schmidt, C.S, Hennessey, J.P

Get full text

Treatment of complicated Candida vaginitis: Comparison of single and sequential doses of fluconazole by Sobel, J.D., Kapernick, P.S., Zervos, M., Reed, B.D., Hooton, T., Soper, D., Nyirjesy, P., Heine, M.W., Willems, J., Panzer, H., Wittes, H.

“…Objective: An attempt was made to validate recent recommendations that women with complicated Candida vaginitis (severe or recurrent, non-albicans Candida spp…”
Get full text

Varicella-Zoster Virus (Chickenpox) Infection in Pregnancy by Lamont, R.F, Sobel, J.D, Carrington, D, Mazaki-Tovi, S, Kusanovic, J.P, Vaisbuch, E, Romero, R

“…(BJOG. 2011;118(10):1155–62)…”
Get full text

P977 Safety and tolerability of voriconazole compared to amphotericin B followed byfiuconazole in patients with candidaemia and baseline renal insufficiency by Oude Lashof, A.M.L, Sobel, J.D, Ruhnke, M, Pappas, P.G, Viscoli, C, Schlamm, H.T, Rex, J.H, Kullberg, B.J

Get full text

Long term outcomes of women with recurrent vulvovaginal candidiasis after a course of maintenance fluconazole by Crouss, T., Sobel, J.D., Smith, K., Nyirjesy, P.

Get full text

Results from RADIANT, a phase 2, randomized, open-label, sponsor-blinded study of CD101 topical in patients with moderate-to-severe acute vulvovaginal candidiasis by Nyirjesy, P., Jandourek, A., Lee, J., Sandison, T., Sobel, J.D.

Get full text

Results from a phase 2, randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety of VT 1161 oral tablets in the treatment of patients with recurrent vulvovaginal candidiasis by Sobel, J.D., Brand, S.R., Degenhardt, T.P., Person, K., Nyirjesy, P., Schotzinger, R.J., Tavakkol, A.

Get full text

Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades by Bulik, C.C, Sobel, J.D, Nailor, M.D

“…Current treatment options for vulvovaginal candidiasis due to Candida albicans include over-the-counter and prescription antifungal agents. Fluconazole has…”
Get full text

Metronidazole gel prevents recurrences of bacterial vaginosis by Sobel, J.D, Ferris, D, Schwebke, J

Get full text

Late recurrence of resistant Trichomonas vaginalis vaginitis: relapse or re-infection? by Kanno, M, Sobel, J D

“…Distinguishing between re-infection and relapse of trichomonas infections is often a difficult task in the clinical setting. The chronicity of trichomonas…”
Get full text

S026 Recurrent vulvovaginal candidiasis (RVVC) by Sobel, J.D.

Get full text

Management of asymptomatic candiduria by Sobel, J.D.

“…Candiduria is a common nosocomial infection, occurring predominantly in elderly debilitated subjects with frequent co-morbid pathology, especially diabetes…”
Get full text

Proton translocating ATPase mediated fungicidal activity of a novel complex carbohydrate: CAN-296 by Ben-Josef, A.M, Manavathu, E.K, Platt, D, Sobel, J.D

“…CAN-296 is a complex carbohydrate (approximately 4300 Da) isolated from the cell wall of Mucor rouxii. It exhibits excellent in vitro fungicidal activity…”
Get full text

Long-Term Follow-Up of Patients with Bacterial Vaginosis Treated with Oral Metronidazole and Topical Clindamycin by Sobel, J. D., Schmitt, C., Meriwether, C.

Get full text

Vaginal infections in adult women by Sobel, J D

“…Often trivialized by the medical profession, vaginitis in adult women is not only extremely common but is the source of considerable distress and often results…”
Get more information

Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis by LYNCH, M. E, SOBEL, J. D, FIDEL, P. L

“…The aetiology of recurrent vulvovaginal candidiasis (RVVC) caused by Candida albicans remains unclear. To adequately address the role of antifungal resistance…”
Get full text

Bacterial etiologic agents in the pathogenesis of urinary tract infection by Sobel, J D

“…Most of the information available concerning virulence factors of uropathogens is based on studies of Escherichia coli, the commonest cause of urinary tract…”
Get more information

Imipenem and aztreonam by Sobel, J D

“…To date, clinical use of aztreonam has been remarkably restrained and widespread enthusiasm for addition to hospital formularies similarly moderate. Its most…”
Get more information

Candida infections in the intensive care unit by Sobel, J D

“…Infections caused by Candida species are now endemic and entrenched in the intensive care unit setting. Candida infections continue to provide a major…”
Get more information